JALYN SUMMARY
JALYN (dutasteride and tamsulosin hydrochloride) Capsules contain dutasteride (a selective inhibitor of both the type 1 and type 2 isoforms of steroid alpha-reductase, an intracellular enzyme that converts testosterone to dihydrotestosterone (DHT) and tamsulosin (an antagonist of alpha1A-adrenoceptors in the prostate). Each JALYN Capsule contains the following: - One dutasteride oblong, opaque, dull-yellow soft gelatin capsule, containing 0.5 mg of dutasteride dissolved in a mixture of butylated hydroxytoluene and mono-di-glycerides of caprylic/capric acid.
JALYN™ (dutasteride and tamsulosin hydrochloride) Capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
|
|
NEWS HIGHLIGHTSMedia Articles Related to Jalyn (Dutasteride / Tamsulosin)
Cook Medical Announces CE Mark Approval For PVA Foam Embolization Particles To Treat Benign Prostatic Hyperplasia Source: Prostate / Prostate Cancer News From Medical News Today [2013.05.03] Cook Medical has received CE Mark approval for its PVA Foam Embolization Particles to be used for the treatment of symptomatic benign prostatic hyperplasia (BPH). The product will be shown at this year's Global Embolization Symposium and Technologies (GEST) conference in Prague, Czech Republic, on 1-4 May...
Benign Prostatic Hyperplasia (Enlarged Prostate) Quiz Source: MedicineNet doxazosin mesylate Specialty [2012.02.29] Title: Benign Prostatic Hyperplasia (Enlarged Prostate) Quiz Category: MedicineNet Quiz Created: 2/7/2012 3:29:00 PM Last Editorial Review: 2/29/2012 6:25:09 PM
Benign Prostatic Hyperplasia Source: MedicineNet Saw Palmetto Specialty [2008.06.23] Title: Benign Prostatic Hyperplasia Category: Diseases and Conditions Created: 12/31/1997 Last Editorial Review: 6/23/2008
Clinical Trials Related to Jalyn (Dutasteride / Tamsulosin)
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer [Recruiting]
The purpose of this study is see if quality of life is improved in patients receiving oral
hormone therapy compared to standard of care. The study will also compare survival rates
between patients receiving oral hormone therapy and those receiving standard of care.
Reports of Suspected Jalyn (Dutasteride / Tamsulosin) Side Effects
Drug Ineffective (17),
Dizziness (17),
Rash (10),
Erectile Dysfunction (9),
Headache (7),
Nocturia (6),
Gynaecomastia (6),
Oedema Peripheral (6),
Dyspnoea (6),
Libido Decreased (6), more >>
|
|
|
|
Page last updated: 2013-05-03
|